603658 Stock Overview
Engages in the research and development, production, marketing, sale, and service of clinical diagnostic products. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 603658 from our risk checks.
Autobio Diagnostics Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥46.49 |
| 52 Week High | CN¥66.36 |
| 52 Week Low | CN¥37.56 |
| Beta | -0.0088 |
| 11 Month Change | 4.47% |
| 3 Month Change | 18.08% |
| 1 Year Change | -2.70% |
| 33 Year Change | -19.15% |
| 5 Year Change | -43.26% |
| Change since IPO | 187.80% |
Recent News & Updates
Recent updates
Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate
Aug 09
Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet
Jul 18Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?
May 21Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings
Feb 27Shareholder Returns
| 603658 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 1.7% | -2.4% | -3.4% |
| 1Y | -2.7% | -5.5% | 6.1% |
Return vs Industry: 603658 exceeded the CN Medical Equipment industry which returned -5.5% over the past year.
Return vs Market: 603658 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 603658 volatility | |
|---|---|
| 603658 Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 603658 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603658's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 5,539 | Zeng Li Yang | www.autobio.com.cn |
Autobio Diagnostics Co., Ltd. engages in the research and development, production, marketing, sale, and service of clinical diagnostic products. It develops immunoassay, biochemistry, and microbiology products, as well as reagents; and instruments, as well as medical laboratory solutions. The company’s immunoassay products AutoLumo A1860 that provides user experience for small and medium size labs; an automated chemiluminescence immunoassay analyzer; AutoLumo A2000 Plus, an automatic chemiluminescence immunoassay analyzer; AutoLumo A1000, an automated chemiluminescence immunoassay analyzer; and LUmo microplate luminometers, PHOmo microplate readers, and iWO and iWO-960 microplate washers.
Autobio Diagnostics Co., Ltd. Fundamentals Summary
| 603658 fundamental statistics | |
|---|---|
| Market cap | CN¥26.60b |
| Earnings (TTM) | CN¥1.27b |
| Revenue (TTM) | CN¥4.58b |
20.9x
P/E Ratio5.8x
P/S RatioIs 603658 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603658 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.58b |
| Cost of Revenue | CN¥1.62b |
| Gross Profit | CN¥2.96b |
| Other Expenses | CN¥1.69b |
| Earnings | CN¥1.27b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | 2.22 |
| Gross Margin | 64.69% |
| Net Profit Margin | 27.78% |
| Debt/Equity Ratio | 6.6% |
How did 603658 perform over the long term?
See historical performance and comparison